A new year begins. 2012 is for us, at Lavipharm, the first year of the second century since our establishment. We continue our work with a clear vision, determination, will and persistence, focused to our goal for Innovation in Health.
Season’s Greetings!...
This year, we are sending our holiday wishes through a child’s painting, created by Maria Koumoutsi. Maria, 9 years old, won the “100 years, countless wishes for 2011” competition organized by Lavipharm with the participation of employees’ children. With their pure and virtuous drawings children...
This year, we wish you happy holidays the “Lavipharm” way. This year’s holiday card is created for Lavipharm by Lavipharm.
Many children of Lavipharm employees participated in a drawing contest with the theme “One star, one wish and lots of music following the festive dance of...
Peania, March 4th 2019 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, on February 28th 2019, T & A Holdings (Luxembourg) Sarl, a company related to Lavipharm SA's...
Peania, March 7th 2019 - Lavipharm S.A., pursuant to Article 19 of the European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that, on March 4th 2019, T & A Holdings (Luxembourg) Sarl, a company related to Lavipharm SA's...
Peania, March 14, 2019 - Lavipharm S.A., pursuant to article 17 of the European Parliament and Council Regulation 596/2014 (EU) and its Board of Directors meeting held on 11.03.2019, hereby notifies the investor community that it will participate to the share capital increase amounting to...
Peania, February 9th, 2018 - Lavipharm S.A., pursuant to Article 19 of European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that on 07.02.2018, T & A Holdings (Luxembourg) sarl, a company related to Lavipharm SA's Executive Chairman, Mr....
Peania, June 15th, 2018 - The Ordinary Annual Shareholders Meeting of Lavipharm SA took place on Friday, June 15th, at the company's headquarters in Peania, with a 54.48% quorum.
During the Shareholders’ Meeting, the management team presented all topics of the agenda along with the Annual...
Peania, June 29th 2018 - Lavipharm S.A., pursuant to Article 19 of European Parliament Regulation No 596/2014 and its Board dated 16/04/2014, hereby informs the investment community that on 28.06.2018, T & A Holdings (Luxembourg) sarl, a company related to Lavipharm SA's Executive Chairman, Mr....
Paiania, September 28, 2018 – Lavipharm demonstrated a solid performance in the first half of 2018. Despite the significant increase of obligatory rebates and clawbacks that burdened the pharma industry, Lavipharm sustained its Turnover and profitability, both at a consolidated and at parent company levels.
More...
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy
Privacy Overview
COOKIE POLICY
The website www.lavipharm.com collects data from visitors/users using cookies. Cookies are small text files that are stored on the hard disk of each visitor/user and do not take note of any document or file from his/her computer. They are used to facilitate the visitor/user's access to the use of specific services on the website www.lavipharm.com for statistical purposes and to determine which areas are useful or popular. These data may also include the type of browser used by the visitor/user, the type of computer, its operating system, Internet service providers and other information of this kind. The visitor/user of the website can set up his program for surfing the web browser in such a way that either warns him about the use of cookies in specific services or does not allow the acceptance of use cookies in any case. In case the visitor/user of the specific services and pages does not wish to use cookies to identify him, he may not have further access to these services. We use the following types of cookies:
Performance cookies: Performance cookies collect information about how visitors/users use the site, for example, which pages they visit most often and if they receive error messages from web pages. They also collect aggregated, anonymous information that does not identify a visitor/user. They are used exclusively to improve the performance of a website.
Functionality cookies: Functionality cookies are used to provide services requested by the visitor/user, such as viewing videos or using social media. The information that these cookies collect may become anonymous and cannot monitor the activity of browsing on other websites. If you do not accept these cookies, it may affect the performance and functionality of the website and limit your access to its content.
Targeting/advertising cookies: They are used to provide content that is more suited to you and your interests. They can be used to send targeted advertising/promotions, limit ads, or measure an ad campaign's effectiveness. It can be used to remember the websites you have visited to determine which online marketing channels are more effective and allow us to reward external websites and partners who have forwarded you to us.
For more information on protecting your privacy, please refer to our Privacy Policy.
Privacy Policy
Data Controller
The company under the name “Commercial and Industrial, Chemical and Cosmetic Products Lavipharm Société Anonyme”, Registration Number: 000298301000, Agias Marinas Street, Paiania, P.C. 19002, Attica, Greece (hereinafter the "Company") is the responsible person and the Data Controller, as defined under the applicable law, for the processing of your personal data under this Privacy Policy.
Types of data we collect
The Company collects personal information of visitors/users of the website www.lavipharm.com, only when they voluntarily provide them for the purpose of providing the services that are available electronically. It also collects and processes personal data from other sources that it obtains legally and is allowed to process.
Indicatively, the personal data collected and processed by the Company include:
• Identity data (name, status, date of birth, VAT number, SS number etc.)
• Contact data (home address, e-mail, telephone number, etc.)
• Financial data (card details, bank account, credit balances, etc.)
• Demographic data (age, gender, place of residence, etc.)
• Data from receiving CVs for evaluating prospective employees
• Consumer health data, in accordance with Company’s pharmacovigilance obligations under current legislation
• Data via Cookies (see Cookies Policy)
Purposes for processing your data
We collect and process your personal data for the following indicative purposes:
• Provision of medical information for the Company's products
• Dispatch of promotional/informative, advertising programs of the Company
• Job placements
• Communicating with website visitors
• Compliance with the applicable legislation (tax legislation, pharmaceutical legislation, recommendations and decrees of the National Organization for Medicines, etc.)
• Improve our products and services, as well as our communication with you
Lawfulness of processing
We process personal data for one or more of the following restrictive reasons:
• Compliance with the Company's legal obligations
• To defend the Company's legitimate business interest, unless the interests or fundamental rights and freedoms of the data subject prevail over it and require the protection of the relevant data;
• Execution of a contract to which you are a contracting party
• Consent of the data subject
Retention time of your personal data
We will retain your personal data for as long as we maintain any business or other relationship with you. To determine the time period for keeping your data, the following criteria are considered:
• The nature of the data
• The purpose of the processing
• The legal obligations of the Company that enforce their compliance
• The value of the data for the Company
• The risks to the Company and the data subjects that may result from the retention of the relevant data
In the event that the necessary period of maintenance of your data expires, these data will be deleted from the Company's databases, unless further compliance is imposed by the need to comply with a relevant provision of law or a contractual obligation of Company.
Transfer and disclosure of your personal data
The Company does not transmit your personal data to countries outside the European Economic Area (third countries) and undertakes not to sell, rent or in any way publish and/or share your personal data with any third party natural or legal person, unless:
• Has the explicit consent of the data subject;
• The transmission of your personal data to legal and/or natural persons cooperating with the Company becomes necessary for the provision of the services and the satisfacaction of your desires;
• The transmission of your personal data is due to the compliance of the Company with the relevant provisions of the law and is restricted to the competent authorities (tax authorities, auditing companies, National Organization for Medicines etc.)
Protection and security of your personal data
Our Company takes the appropriate technical and organizational measures for the protection and security of your personal data. We use various security measures and technologies to protect your personal data against unauthorized access, use, disclosure, alteration or destruction, in accordance with the relevant laws on the protection and confidentiality of personal data, such as anonymization, misrepresentation, data encryption, firewalls, principles of data protection already by design and by definition, and organizational measures such as strict policies for access to systems, employee confidentiality, establishment of internal procedures, staff training, periodic audits, etc.
When we share or transmit your personal data with third parties, we contractually ensure that they keep your data confidential and implement appropriate security measures to maintain the security of your data.
Your Rights
As personal data subjects, you have the following rights, as defined and specified in the Regulation (EU) 2016/679 (General Data Protection Regulation/GDPR):
the right of access, i.e. upon your request, to inquire as to whether or not your personal data are being processed and to obtain further information on it;
the right to demand the rectification of your personal data in the event of an inaccurate registration or subsequent change;
the right to obtain the restriction of the processing, under the conditions laid down in the law;
the right to the portability of your data;
the right to ask the erasure of your personal data, subject to the applicable legislation;
the right to withdraw your consent;
the right to file a complaint to the Personal Data Protection Authority (Kifissias 1-3, P.C. 115 23, Athens, call center: + 30-210 6475600, Fax: + 30-210 6475628). For the authority's responsibility and how to submit a complaint, you can visit the website (www.dpa.gr = "My rights =" submit a complaint), where there is detailed information.
In order to exercise these rights you may contact Lavipharm Group's Data Protection Officer (DPO), by sending your request either to the email address: dpo@lavipharm.com, or by post at the Company’s offices, Agias Marinas Street, Paiania Attikis, P.C. 19002.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.